Instrument Inactif

Autres langues 4D pharma plc

Actions

DDDD

GB00BJL5BR07

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

4D Pharma shares cancelled from trading on London's AIM	15/02/23
4D pharma Cancels Trading on London's AIM	15/02/23
TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil	03/02/23
4D pharma plc Updates Results from Renal Cell Carcinoma Cohort	02/02/23
UK shareholder meetings calendar - next 7 days	09/01/23
4D Pharma seeks approval for equity fundraise to lift suspension	30/12/22
4D pharma's Blautix Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics	18/11/22
4D Pharma says trial results show Blautix eases IBS symptoms	16/11/22
4D pharma : Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022) - Form 6-K	15/11/22
4D pharma : Presents at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022)	10/11/22
4D pharma : Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022) - Form 6-K	07/10/22
4D pharma : Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022)	05/10/22
4D pharma Remains Suspended from Trading on London's AIM	29/09/22
4D Pharma plc Announces Delay in Publication of Interim Results for the Six Months to 30 June 2022	29/09/22
4D pharma : Publication of Joint Administrators’ Proposals - Form 6-K	24/08/22
4D pharma plc Announces Publication of Preclinical Research Showing Live Biotherapeutic MRx0006 Efficacy in Animal Model of Autism Spectrum Disorder	24/08/22
4D pharma plc(NasdaqGM:LBPS) dropped from NASDAQ Composite Index	06/07/22
4D Pharma plc Is Temporarily Pausing Recruitment into Ongoing Clinical Trials	05/07/22
4D Pharma Temporarily Halts Patient Enrollment In Clinical Trials For Cancer, Asthma, Parkinson's Disease Drugs	04/07/22
4D PHARMA : “4D pharma”) RECEIVES NOTICE OF DELISTING FROM NASDAQ - Form 6-K	29/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues 4D pharma plc

Actions

DDDD

GB00BJL5BR07

Autres langues

Filtres